SavedAdd your journal

Journals / The anatolian journal of family medicine (Online) / 2020 / Cilt: 3 - Sayı: 2

Evaluation of Toxoplasma gondii, Rubella virus and Cytomegalovirus Infections

Hilal ALBAYRAK
Ayfer BAKIR
Mustafa GÜNEY
Mehmet YAVUZ
Pages
136–140
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, thefindings suggest that pregnant women and women of childbearing age should be investigated concerning T.gondii, the rubella virus and CMV antibodies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Primary infection agents occurring during pregnancy and causing congenital anomalies are Toxoplasma gondii (T.gondii), rubella virus and cytomegalovirus (CMV).
📊
Key Findings & Data:It was revealed that these agents infectedthe fetus by crossing the placenta and increased the rate of fetal morbidity and mortality.
💡
Conclusion & Impact:Therefore, thefindings suggest that pregnant women and women of childbearing age should be investigated concerning T.gondii, the rubella virus and CMV antibodies.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: Primary infection agents occurring during pregnancy and causing congenital anomalies are Toxoplasma gondii (T.gondii), rubella virus and cytomegalovirus (CMV). It was revealed that these agents infectedthe fetus by crossing the placenta and increased the rate of fetal morbidity and mortality. This study aimed toinvestigate the relationship between seroprevalences of T. gondii, rubella virus and CMV antibodies.Methods: The results were retrospectively evaluated. Pregnant women’s serum samples sent to the Medical Microbiology Laboratory of Ankara Gülhane Training and Research Hospital between January 2018 andDecember 2018 were included in this study. T. gondii, rubella virus and CMV IgM and IgG antibodies wereanalysed using the chemiluminescent immunoassay method.Results: In this study, the results of 647 pregnant patients were retrospectively analysed. The median age ofthe attendants was 28.0 (18.0-49.0) years. IgM positivities for T. gondii, rubella virus and CMV were found as 3(0.6%), 3 (0.5%) and 61 (15.0%) respectively and IgG positivities were 66 (13.8%), 529 (91.7%) and 394 (99.3%),respectively.Conclusion: In this study, the results were consistent with the findings obtained in the regional studies. Seroprevalence studies in pregnant women will be guide for the necessity of prenatal screening tests. Therefore, thefindings suggest that pregnant women and women of childbearing age should be investigated concerning T.gondii, the rubella virus and CMV antibodies.

🔖

Cite This Article

ALBAYRAK, H., BAKIR, A., GÜNEY, M., YAVUZ, M. (2020). Evaluation of Toxoplasma gondii, Rubella virus and Cytomegalovirus Infections. The anatolian journal of family medicine (Online), Cilt: 3 - Sayı: 2, 136–140. https://ajindex.com/articles/365026

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rasti S, Ghasemi FS, Abdoli A, Piroozmand A, Mousavi SG, Fakhrie-Kashan Z. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women. Congenit Anom (Kyoto) 2016;56(2):73–8
  2. Prasoona KR, Srinadh B, Sunitha T, Sujatha M, Deepika ML, Vijaya Lakshmi B, et al. Seroprevalence and Influence of Torch Infections in High Risk Pregnant Women: A Large Study from South India. J Obstet Gynaecol India 2015;65(5):301–9
  3. Boyer SG, Boyer KM. Update on TORCH infections in the newborn infant. NAINR 2004;4(1):70–80
  4. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 2009;39(12):1385–94
  5. Leeper C, Lutzkanin A. Infections During Pregnancy. Prim Care 2018;45(3):567–86
  6. Nyholm JL, Schleiss MR. Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health 2010;2:23–35
  7. Margioula-Siarkou C, Kalogiannidis I, Petousis S, Prapa S, Dagklis T, Mamopoulos A, et al. Cytomegalovirus, Toxoplasma gondii and Rubella Vertical Transmission Rates According to Mid-trimester Amniocentesis: A Retrospective Study. Int J Prev Med 2015;6:32
  8. Surpam RB, Kamlakar UP, Khadse R, Qazi M, Jalgaonkar SV. Serological study for TORCH infections in women with bad obstetric history. J Obstet Gynecol India 2006;56(1):41–3
  9. Turbadkar D, Mathur M, Rele M. Seroprevalence of torch infection in bad obstetric history. Indian J Med Microbiol 2003;21(2):108–10
  10. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med 2014;370(23):2211–8
  11. Tamer GS, Dundar D, Caliskan E. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med 2009;32(1):E43–7
  12. Singh S, Munawwar A, Rao S, Mehta S, Hazarika NK. Serologic prevalence of Toxoplasma gondii in Indian women of child bearing age and effects of social and environmental factors. PLoS Negl Trop Dis 2014;8(3):e2737
  13. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012;25(2):264–96
  14. Kasap B, Öner G, Küçük M, Öztürk Turhan N, Akın MN, Arıkan S, et al. The Evaluation of Toxoplasmosis, Rubella, Cytomegalovirus and Hepatitis Prevalence of Pregnant Women in Muğla. Tepecik Eğit Hast Derg 2017;27(1):31–6
  15. Duran İ, Nazik S, Nazik H, Duran Ş. Gebelikte Toksoplazma ve Rubella seropozitifliğini d